Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 2,037,560 |
|
|||||
| News | - | ||||||
| Day High | 0.1066 | Low High |
|||||
| Day Low | 0.101 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kintara Therapeutics Inc | KTRA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0157 | 15.13% | 0.1195 | 19:59:54 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.1015 | 0.101 | 0.1066 | 0.1066 | 0.1038 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,739 | 2,037,560 | $ 0.1039145 | $ 211,732 | - | 0.081 - 5.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:46 | formt | 500 | $ 0.1195 | USD |
Kintara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.29M | 39.04M | - | 0 | -15.02M | -0.38 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kintara Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KTRA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.1188 | 0.1288 | 0.101 | 0.1163329 | 2,972,466 | 0.0007 | 0.59% |
| 1 Month | 0.0926 | 0.24 | 0.086 | 0.1481052 | 17,961,557 | 0.0269 | 29.05% |
| 3 Months | 0.1141 | 0.24 | 0.081 | 0.1255829 | 14,624,248 | 0.0054 | 4.73% |
| 6 Months | 3.81 | 4.5861 | 0.081 | 0.1449636 | 9,580,892 | -3.69 | -96.86% |
| 1 Year | 3.52 | 5.98 | 0.081 | 0.1858009 | 4,802,046 | -3.40 | -96.61% |
| 3 Years | 69.50 | 142.50 | 0.081 | 10.64 | 2,655,072 | -69.38 | -99.83% |
| 5 Years | 60.50 | 167.50 | 0.081 | 15.14 | 2,298,466 | -60.38 | -99.80% |
Kintara Therapeutics Description
| Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. |
